Revitalise Your Lymphatic System with LYMPHOGENiX
LYMPHOGENiX is a pioneer in lymphatic vessel regeneration. Our proprietary technology revitalizes lymphatic function and promotes regeneration of various medical conditions. We envision our methods to treat heart failure, pulmonary fibrosis and with substantial potential to tackle skin-ageing, obesity, Alzheimer’s Disease and infertility as well. We believe in helping patients improve their vitality, one treatment at a time.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Covent Garden, London,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.lymphogenix.com
- Keywords
- Lymphatic system, Biotech, Startup, heart failure, pulmonary fibrosis, skin-ageing, obesity, Alzheimer’s Disease, infertility, UK, Harwell, Nagoya University, Japan, HFrEF, HFpEF, Biospire, Metcela.
- HQ
- London
Lymphogenix Questions
Lymphogenix's website is http://www.lymphogenix.com
Lymphogenix's LinkedIn profile is https://uk.linkedin.com/company/lymphogenix
Lymphogenix has
2 employees.
View email and phone details for 2
employees at Lymphogenix.
Lymphogenix's industry is
Biotechnology Research
Lymphogenix's top competitors are
New Wave Biotech,
Jichi Medical University,
Twig Bio,
Thymia,
Tolemy Bio,
Vivan Therapeutics,
Conserv Bioscience,
Metcela Inc.,
Seedna-Old,
Leap Labs.
Lymphogenix's categories are Biotechnology Research
Lymphogenix's founding year is 2024
